These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

554 related items for PubMed ID: 37451151

  • 1. Quercetin induces MGMT+ glioblastoma cells apoptosis via dual inhibition of Wnt3a/β-Catenin and Akt/NF-κB signaling pathways.
    Wang W, Yuan X, Mu J, Zou Y, Xu L, Chen J, Zhu X, Li B, Zeng Z, Wu X, Yin Z, Wang Q.
    Phytomedicine; 2023 Sep; 118():154933. PubMed ID: 37451151
    [Abstract] [Full Text] [Related]

  • 2. Muscone restores anoikis sensitivity in TMZ-resistant glioblastoma cells by suppressing TOP2A via the EGFR/Integrin β1/FAK signaling pathway.
    Zou Y, Xu L, Wang W, Zhu X, Lin J, Li H, Chen J, Xu W, Gao H, Wu X, Yin Z, Wang Q.
    Phytomedicine; 2024 Jul; 129():155714. PubMed ID: 38723526
    [Abstract] [Full Text] [Related]

  • 3. Tubeimoside-I sensitizes temozolomide-resistant glioblastoma cells to chemotherapy by reducing MGMT expression and suppressing EGFR induced PI3K/Akt/mTOR/NF-κB-mediated signaling pathway.
    Tang Q, Cao H, Tong N, Liu Y, Wang W, Zou Y, Xu L, Zeng Z, Xu W, Yin Z, Ma W, Wang Q.
    Phytomedicine; 2022 May; 99():154016. PubMed ID: 35278900
    [Abstract] [Full Text] [Related]

  • 4. β-catenin contributes to cordycepin-induced MGMT inhibition and reduction of temozolomide resistance in glioma cells by increasing intracellular reactive oxygen species.
    Bi Y, Li H, Yi D, Bai Y, Zhong S, Liu Q, Chen Y, Zhao G.
    Cancer Lett; 2018 Oct 28; 435():66-79. PubMed ID: 30081068
    [Abstract] [Full Text] [Related]

  • 5. IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastoma.
    Guo G, Sun Y, Hong R, Xiong J, Lu Y, Liu Y, Lu J, Zhang Z, Guo C, Nan Y, Huang Q.
    Clin Transl Oncol; 2020 Aug 28; 22(8):1252-1262. PubMed ID: 31865606
    [Abstract] [Full Text] [Related]

  • 6. Up-Regulation of Cyclooxygenase-2 (COX-2) Expression by Temozolomide (TMZ) in Human Glioblastoma (GBM) Cell Lines.
    Lombardi F, Augello FR, Artone S, Gugu MK, Cifone MG, Cinque B, Palumbo P.
    Int J Mol Sci; 2022 Jan 28; 23(3):. PubMed ID: 35163465
    [Abstract] [Full Text] [Related]

  • 7. Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway.
    Bi Y, Li H, Yi D, Sun Y, Bai Y, Zhong S, Song Y, Zhao G, Chen Y.
    Mol Pharm; 2018 Nov 05; 15(11):4912-4925. PubMed ID: 30336060
    [Abstract] [Full Text] [Related]

  • 8. BKM120 sensitizes C6 glioma cells to temozolomide via suppression of the PI3K/Akt/NF-κB/MGMT signaling pathway.
    Li M, Liang RF, Wang X, Mao Q, Liu YH.
    Oncol Lett; 2017 Dec 05; 14(6):6597-6603. PubMed ID: 29151909
    [Abstract] [Full Text] [Related]

  • 9. NBM-BMX, an HDAC8 Inhibitor, Overcomes Temozolomide Resistance in Glioblastoma Multiforme by Downregulating the β-Catenin/c-Myc/SOX2 Pathway and Upregulating p53-Mediated MGMT Inhibition.
    Tsai CY, Ko HJ, Chiou SJ, Lai YL, Hou CC, Javaria T, Huang ZY, Cheng TS, Hsu TI, Chuang JY, Kwan AL, Chuang TH, Huang CF, Loh JK, Hong YR.
    Int J Mol Sci; 2021 May 31; 22(11):. PubMed ID: 34072831
    [Abstract] [Full Text] [Related]

  • 10. COXIBs and 2,5-dimethylcelecoxib counteract the hyperactivated Wnt/β-catenin pathway and COX-2/PGE2/EP4 signaling in glioblastoma cells.
    Majchrzak-Celińska A, Misiorek JO, Kruhlenia N, Przybyl L, Kleszcz R, Rolle K, Krajka-Kuźniak V.
    BMC Cancer; 2021 May 03; 21(1):493. PubMed ID: 33941107
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of NF-κB results in anti-glioma activity and reduces temozolomide-induced chemoresistance by down-regulating MGMT gene expression.
    Yu Z, Chen Y, Wang S, Li P, Zhou G, Yuan Y.
    Cancer Lett; 2018 Aug 01; 428():77-89. PubMed ID: 29705182
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. 20(S)-ginsenoside-Rg3 reverses temozolomide resistance and restrains epithelial-mesenchymal transition progression in glioblastoma.
    Chen Z, Wei X, Shen L, Zhu H, Zheng X.
    Cancer Sci; 2019 Jan 01; 110(1):389-400. PubMed ID: 30431207
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A steroidal saponin form Paris vietnamensis (Takht.) reverses temozolomide resistance in glioblastoma cells via inducing apoptosis through ROS/PI3K/Akt pathway.
    Zhang S, Lu Y, Li H, Ji Y, Fang F, Tang H, Qiu P.
    Biosci Trends; 2020 May 21; 14(2):123-133. PubMed ID: 32173672
    [Abstract] [Full Text] [Related]

  • 16. Demethoxycurcumin Suppresses Proliferation, Migration, and Invasion of Human Brain Glioblastoma Multiforme GBM 8401 Cells via PI3K/Akt Pathway.
    Su RY, Hsueh SC, Chen CY, Hsu MJ, Lu HF, Peng SF, Chen PY, Lien JC, Chen YL, Chueh FS, Chung JG, Yeh MY, Huang YP.
    Anticancer Res; 2021 Apr 21; 41(4):1859-1870. PubMed ID: 33813391
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Resveratrol reverses temozolomide resistance by downregulation of MGMT in T98G glioblastoma cells by the NF-κB-dependent pathway.
    Huang H, Lin H, Zhang X, Li J.
    Oncol Rep; 2012 Jun 21; 27(6):2050-6. PubMed ID: 22426504
    [Abstract] [Full Text] [Related]

  • 19. Activated TRPA1 plays a therapeutic role in TMZ resistance in glioblastoma by altering mitochondrial dynamics.
    Chen H, Li C, Hu H, Zhang B.
    BMC Mol Cell Biol; 2022 Aug 19; 23(1):38. PubMed ID: 35982414
    [Abstract] [Full Text] [Related]

  • 20. Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway.
    Yu X, Wang M, Zuo J, Wahafu A, Mao P, Li R, Wu W, Xie W, Wang J.
    Life Sci; 2019 Nov 01; 236():116917. PubMed ID: 31614149
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.